Los puntos clave no están disponibles para este artículo en este momento.
This survey study examines how well physicians understand the US Food and Drug Administration’s (FDA’s) statutory definition of a “breakthrough” therapy, and whether the term breakthrough affects their perceptions of a drug’s efficacy.
Kesselheim et al. (Tue,) studied this question.